India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, FY 2026
India molecular diagnostics market stood at an estimated $ 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases.Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive market growth during the forecast period.
Furthermore, government initiatives of raising funds for the country’s molecular department is also expected to positively influence the market in the coming years.However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle.
Also, with over 25% of the country’s population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market during the forecast period.
India molecular diagnostics market is segmented into application, technology, end user, and region. Based on application, the market is further fragmented into infectious disease, blood screening, genetic testing and oncology testing, out of which oncology testing segment is expected to dominate the market until FY 2026, followed by the infectious disease segment.
Major players operating in India molecular diagnostics market include Roche Diagnostics India Pvt Ltd, Abbott India Limited, Qiagen India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Biocartis, Bio-Techne India Private Limited, Danaher, Bio-Rad laboratories India Pvt.Ltd, Cleaver Scientific, etc.
• To analyze and estimate the market size of India molecular diagnostics market from FY2016 to FY2020. • To estimate and forecast the market size of India molecular diagnostics market from FY2021 to FY2026. • To classify and forecast India molecular diagnostics market based on application, technology, end user, region and company. • To identify dominant region or segment in the India molecular diagnostics market. • To identify drivers and challenges for India molecular diagnostics market. • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India molecular diagnostics market. • To conduct pricing analysis for India molecular diagnostics market. • To identify and analyze the profile of leading players operating in India molecular diagnostics market. • To identify key sustainable strategies adopted by market players in India molecular diagnostics market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of service providers across the country.
Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.
Through this technique, the analyst could include the service providers which could not be identified due to the limitations of secondary research. The analyst examined the service providers, distribution channels and presence of all major players across the country. The analyst calculated the market size of India molecular diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.
Key Target Audience:
• End users, hospitals, and laboratories • Market research and consulting firms • Government bodies such as regulating authorities and policy makers • Organizations, forums, and alliances related to molecular diagnostics The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, India molecular diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • Market, By Application: o Infectious disease o Blood screening o Genetic testing o Oncology testing • Market, By Technology: o PCR o In-situ hybridization o Chips and microarrays o Mass spectrometry o Sequencing o Others • Market, By End User: o Hospitals o Academic & Reference Laboratories • Market, By Region: North o East o West o South
Company Profiles: Detailed analysis of the major companies present in India molecular diagnostics market.
With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
Our reports have been used by over 10K customers, including:
The global oncology molecular diagnostics market grew at a CAGR of around 12% during 2014-2019. Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific...
375 pages •
By Global Industry Analysts
• Sep 2020
Global Multiplex Assays Market to Reach $4 Billion by 2027 Amid the COVID-19 crisis, the global market for Multiplex Assays estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 6.3% over the analysis period 2020-2027. Consumables, one of the segments analyzed...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
G-protein coupled receptors market is anticipated to be driven by rising number of cancer cases, rising prevalence of lifestyle-related issues, such as cardiovascular infections, and respiratory issues. G-protein coupled receptors (GPCRs) are exceptionally helpful in the innovative work of newer medication substances. Furthermore, the increasing...
The Digital PCR market is projected to register a CAGR of nearly 17.8% over the forecast period. The major factor attributing to the growth of the market is the rising diagnostics and screening tests of diseases like cancer, hereditary, and infectious diseases, and the growing demand for parental testing and gene study. As per GLOBOCAN, the...
Glucose Dependent Insulinotropic Receptor - Pipeline Review, H2 2020 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) pipeline Target constitutes close to 8 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the...
Overview Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening and to a number of emerging applications in other diseases. The global market for molecular diagnostics is expected to grow at a CAGR of 10.8% between...
226 pages •
By Global Industry Analysts
• Sep 2020
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $4.3 Billion by 2027 Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR...
Isothermal Nucleic Acid Amplification Technology Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Isothermal Nucleic Acid Amplification Technology...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.